MyAverix Finance
US · Healthcare
Scancell Holdings plc (SCNLF)
Biotechnology
Scancell Holdings plc (SCNLF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SCNLF
Scancell Holdings plc (SCNLF) — FAQ
What is SCNLF's P/E ratio?
The price-to-earnings (P/E) ratio for Scancell Holdings plc (SCNLF) is 25.00 (data as of 2026-05-23).
Does Scancell Holdings plc pay a dividend?
Dividend yield is not available in the current snapshot for Scancell Holdings plc (SCNLF). Check the MyAverix Finance app for the latest dividend data.
What sector is Scancell Holdings plc in?
Scancell Holdings plc (SCNLF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SCNLF listed on?
SCNLF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.